Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study.

MLA

Buggisch, Peter, et al. “Barriers to Initiation of Hepatitis C Virus Therapy in Germany: A Retrospective, Case-Controlled Study.” PloS One, vol. 16, no. 5, May 2021, p. e0250833. EBSCOhost, https://doi.org/10.1371/journal.pone.0250833.

APA

Buggisch, P., Heiken, H., Mauss, S., Weber, B., Jung, M.-C., Görne, H., Heyne, R., Hinrichsen, H., Hidde, D., König, B., Pires Dos Santos, A. G., Niederau, C., & Berg, T. (2021). Barriers to initiation of hepatitis C virus therapy in Germany: A retrospective, case-controlled study. PloS One, 16(5), e0250833. https://doi.org/10.1371/journal.pone.0250833

Chicago

Buggisch, Peter, Hans Heiken, Stefan Mauss, Bernd Weber, Maria-Christina Jung, Herbert Görne, Renate Heyne, et al. 2021. “Barriers to Initiation of Hepatitis C Virus Therapy in Germany: A Retrospective, Case-Controlled Study.” PloS One 16 (5): e0250833. doi:10.1371/journal.pone.0250833.